Neurotrophic Keratitis

A Multicenter, Randomized, Vehicle-Controlled, Double-Masked to Open-Label Study to Evaluate the Safety and Efficacy of Lacripep 4 μM Ophthalmic Solution in Subjects With Neurotrophic Keratitis

A Study of STSP-0902 Ophthalmic Solution in Healthy Subjects

A Study Comparing KB801 Verse Placebo in Patients With Stage 2 or 3 Neurotrophic Keratitis

QST for Corneal Nerve Function

DEFENDO Long Term Follow-up Study in Stage 1 NK Patients

Study to Evaluate OXERVATE® in Patients With Stage 1 Neurotrophic Keratitis

Corneal Neurotization vs. Cenergermin for Neurotrophic Keratitis: A Pilot Study

A Phase II Study of STSP-0902 Ophthalmic Solution in Patients With Neurotrophic Keratitis

REC 0/0559 Eye Drops for Treatment of Moderate and Severe Neurotrophic Keratitis in Adult Patients

Use of Acthar Gel Single-Dose Pre-Filled SelfJectTM Injector in Patients With Moderate-Severe Keratitis and Autoimmune Disease

DOMPE -MT Neurotrophic Keratitis

Corneal Nerves After Treatment With Cenegermin

Efficacy and Safety of Plasma Rich in Growth Factors (PRGF-Endoret) Eye-drops in the Treatment of Neurotrophic Keratitis

Differences in Corneal Structure and Function in Patients With Sjogrens vs. Non-Sjogrens Dry Eye

Open-label Trial to Evaluate Efficacy and Safety of rhNGF on Corneal Thickness Via AS-OCT in Neurotrophic Keratitis

Assessment of the Initial Efficacy and Safety of BRM424 Ophthalmic Solutions in Patients With Neurotrophic Keratitis

Study to Evaluate the Safety and Efficacy of CSB-001 Ophthalmic Solution 0.1% in Neurotrophic Keratitis Subjects

Evaluation of Safety and Efficacy of rhNGF in Patients With Stage 2 and 3 Neurotrophic Keratitis.

OCT Evaluation of Neurotrophic Ulcer Following Treatment With Oxervate

Topical Insulin Drops for the Treatment of Neurotrophic Keratopathy.